Evidence map›Paper›PMID 20215515›Full record

ArticleCancer research2010

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

S Michael Rothenberg, Gayatry Mohapatra, Miguel N Rivera, Daniel Winokur, Patricia Greninger, Mai Nitta, Peter M Sadow, Gaya Sooriyakumar, Brian W Brannigan, Matthew J Ulman and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dual Function of Par3 in Tumorigenesis.Frontiers in oncology · 2022
    Review
  6. Article
  7. Article
  8. Review
  9. Frontiers in cell and developmental biology · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Partition-Defective 3 (PARD3) Regulates Proliferation, Apoptosis, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Cells.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 1 country.

S Michael RothenbergMassachusetts General Hospital Cancer Center and Center for Molecular Therapeutics, Harvard Medical School, Charlestown, Massachusetts 02129, USA.
Gayatry Mohapatra
Miguel N Rivera
Daniel Winokur
Patricia Greninger
Mai Nitta
Peter M Sadow
Gaya Sooriyakumar
Brian W Brannigan
Matthew J Ulman
Rushika M Perera
Rui Wang
Angela Tam
Xiao-Jun Ma
Mark Erlander
Dennis C Sgroi
James W Rocco
Mark W Lingen
Ezra E W Cohen
David N Louis
Jeffrey Settleman
Daniel A Haber
Massachusetts General Hospital · USBiothera (United States) · USHoward Hughes Medical Institute · USHarvard University · USUniversity of Chicago · US

Funding

Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor CellsR01CA129933 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel A. Haber · 2008 to 2026
$7.5M
TOWARD A MOLECULAR CLASSIFICATION OF HUMAN GLIOMASR01CA057683 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LOUIS, DAVID N · 1992 to 2013
$4.7M
Functional Properties of the Wilms' Tumor Gene WT1R37CA058596 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HABER, DANIEL A. · 2003 to 2011
$3.9M
Functional Characterization of WTX in Renal DevelopmentK08DK080175 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RIVERA, MIGUEL NICOLAS · 2007 to 2011
$687k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA057683NCI NIH HHS R01 CA129933NCI NIH HHS R01 CA207186NCI NIH HHS R01 CA57683NCI NIH HHS R37 CA058596NIDDK NIH HHS K08 DK080175
6 · The paper itself

Abstract

In a genome-wide screen of 684 cancer cell lines, we identified homozygous intragenic microdeletions involving genes encoding components of the apical-basal cell polarity complexes. Among these, PARD3 is disrupted in cell lines and primary tumors from squamous carcinomas and glioblastomas. Reconstituting PARD3 expression in both cell types restores tight junctions and retards contact-dependent proliferation. Searching specifically for small intragenic microdeletions using high-resolution genomic arrays may be complementary to other genomic deletion screens and resequencing efforts in identifying new tumor suppressor genes.

Indexed as

Gene DeletionAdaptor Proteins, Signal TransducingCarcinoma, Squamous CellCell Cycle ProteinsCell Line, TumorGenome, HumanGlioblastomaHead and Neck NeoplasmsHumansIn Situ Hybridization, FluorescenceMembrane ProteinsNeoplasmsReverse Transcriptase Polymerase Chain ReactionRNA, MessengerTight JunctionsAdaptor Proteins, Signal TransducingCell Cycle ProteinsMembrane ProteinsPARD3 protein, humanRNA, Messenger

Identifiers

PMID20215515
PMCPMC2881662
OpenAlexW2061655201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.